Stock ARCOMA ARCOMA AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Arcoma AB

Equities

ARCOMA

SE0006219176

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:30 2024-04-26 am EDT 		5-day change 1st Jan Change
13.5 SEK +2.66% Intraday chart for Arcoma AB +16.38% +69.81%
Apr. 25 Arcoma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Jan. 29 Arcoma AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 250.4 281.2 169.7 100.2 104.8 178 - -
Enterprise Value (EV) 1 248.5 275.1 166.7 97.4 103.7 171 159 141
P/E ratio 38.1 x 183 x -22.8 x 54.9 x 41.8 x 13.1 x 11.2 x 9.78 x
Yield - - - - - - - -
Capitalization / Revenue 1.87 x 2.38 x 1.45 x 0.8 x 0.64 x 0.97 x 0.89 x 0.84 x
EV / Revenue 1.85 x 2.33 x 1.42 x 0.78 x 0.64 x 0.93 x 0.8 x 0.66 x
EV / EBITDA 19 x 39.9 x -62.4 x 10 x 8.14 x 7.77 x 6.63 x 5.42 x
EV / FCF -8,873 x -54.4 x -27.2 x -22.4 x 6.24 x 28.5 x 12.2 x 7.83 x
FCF Yield -0.01% -1.84% -3.67% -4.46% 16% 3.51% 8.18% 12.8%
Price to Book 5.54 x 5.68 x 3.85 x 2.21 x - 2.88 x 2.29 x 1.86 x
Nbr of stocks (in thousands) 12,645 12,780 13,052 13,052 13,186 13,186 - -
Reference price 2 19.80 22.00 13.00 7.680 7.950 13.50 13.50 13.50
Announcement Date 4/29/20 2/18/21 2/10/22 2/9/23 1/29/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 134 117.9 117.1 125 163 183 199 213
EBITDA 1 13.1 6.9 -2.67 9.722 12.75 22 24 26
EBIT 1 9.099 3.598 -8.972 3.125 4.66 14 16 19
Operating Margin 6.79% 3.05% -7.66% 2.5% 2.86% 7.65% 8.04% 8.92%
Earnings before Tax (EBT) 1 8.89 1.838 -8.914 2.121 3.133 14 16 18
Net income 1 6.61 1.435 -7.473 1.902 2.564 14 16 18
Net margin 4.93% 1.22% -6.38% 1.52% 1.57% 7.65% 8.04% 8.45%
EPS 2 0.5200 0.1200 -0.5700 0.1400 0.1900 1.030 1.210 1.380
Free Cash Flow 1 -0.028 -5.058 -6.12 -4.348 16.61 6 13 18
FCF margin -0.02% -4.29% -5.22% -3.48% 10.19% 3.28% 6.53% 8.45%
FCF Conversion (EBITDA) - - - - 130.28% 27.27% 54.17% 69.23%
FCF Conversion (Net income) - - - - 647.7% 42.86% 81.25% 100%
Dividend per Share - - - - - - - -
Announcement Date 4/29/20 2/18/21 2/10/22 2/9/23 1/29/24 - - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 1.91 6.04 3.02 2.84 1.13 7 19 37
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 -0.03 -5.06 -6.12 -4.35 16.6 6 13 18
ROE (net income / shareholders' equity) 15.7% - - 4.23% 5.42% 25% 23% 21%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 3.570 3.870 3.370 3.480 - 4.680 5.890 7.270
Cash Flow per Share 0.8700 - - - - - - -
Capex 1 11.1 11.7 4.19 0.05 - 4 5 5
Capex / Sales 8.3% 9.92% 3.58% 0.04% - 2.19% 2.51% 2.35%
Announcement Date 4/29/20 2/18/21 2/10/22 2/9/23 1/29/24 - - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Imaging Systems

1st Jan change Capi.
ARCOMA AB Stock Arcoma AB
+69.81% 16.24M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD. Stock Shanghai United Imaging Healthcare Co., Ltd.
-5.77% 14.68B
IRAY TECHNOLOGY COMPANY LIMITED Stock iRay Technology Company Limited
-40.71% 2.71B
SONOSCAPE MEDICAL CORP. Stock SonoScape Medical Corp.
-12.92% 2.44B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Wandong Medical Technology Co.,Ltd.
-8.78% 1.51B
CORETAG, INC. Stock Coretag, Inc.
-.--% 1.12B
NANO-X IMAGING LTD. Stock Nano-X Imaging Ltd.
+40.66% 518M
DETECTION TECHNOLOGY OYJ Stock Detection Technology Oyj
+11.68% 239M
VIEWORKS CO., LTD. Stock Vieworks Co., Ltd.
+1.67% 183M
INTROMEDIC CO., LTD. Stock IntroMedic Co., Ltd.
-.--% 168M
Medical Imaging Systems
  1. Stock Market
  2. Equities
  3. ARCOMA Stock
  4. Financials Arcoma AB